Choose another ingredient

THE INGREDIENT LIBRARY · Entry 109

NAC (N-acetylcysteine)

Engraved source or material study: a porcelain dish of fine white crystalline powder, no plant.
Material study: N-acetylcysteine is manufactured · Decorative illustration

At a glance

N-acetyl-L-cysteine · manufactured amino-acid derivative

NAC is a manufactured form of cysteine with a pharmaceutical history: mucus-thinning medicines and emergency treatment for acetaminophen poisoning came before its wider supplement identity. Its sulfur-containing chemistry helps explain those uses, but does not establish everyday detox or general-wellness benefits.

Material and sensory character
A single chemical compound rather than a harvested herb. The medicinal material is a white crystalline powder; some preparations have a noticeable sulfurous odor.
Medical and supplement forms
Oral supplements, licensed oral medicines, inhalation solutions and intravenous products have different intended uses and instructions. Never inject or nebulize an oral supplement.
Modern heritage
Its story runs from twentieth-century respiratory care and emergency toxicology to the language of antioxidant wellness on supplement shelves.
Evidence in context
Established antidote care is distinct from the mixed, diagnosis-specific evidence for longer-term respiratory and psychiatric supplementation.

Key cautions

  • Nausea, reflux, diarrhea or vomiting can occur. Check use with nitroglycerin, asthma, cancer treatment, pregnancy or breastfeeding.
  • Suspected acetaminophen/paracetamol overdose needs immediate emergency or poison-center advice. A supplement dose is not an antidote protocol.
  • Acepiro’s oral label calls for caution with a history of peptic ulcers, histamine intolerance, or kidney or liver impairment. People unable to cough mucus up effectively need clinical assessment before a mucolytic. Its effervescent tablets contain sodium and lactose; check the actual product when salt restriction or relevant sugar intolerance matters.
  • Very rare serious skin reactions have been reported in temporal association with acetylcysteine. Acepiro’s label advises stopping use and seeking immediate medical advice for new skin or mucosal lesions; the association alone does not establish that NAC caused every reported case.
  • ACETADOTE infusion can cause fluid overload and dangerously low blood sodium, in addition to its hypersensitivity risks. These are hospital-treatment precautions, not evidence that oral supplements have the same risk profile.
Read the full cautions

What’s inside

N-acetyl-L-cysteine is the active molecule, with formula C5H9NO3S. It contains sulfur in a thiol group, a reactive part of the molecule involved in its chemistry. Added minerals, flavors, sweeteners and tablet ingredients belong to the individual formulation, not to NAC itself.

DailyMed: Acetylcysteine solution, oral antidote and inhaled mucolytic labeling · Acepiro 600 mg: UK product information, absorption, food and precautions (2025) · NOW Foods: NAC capsules (primary source for the manufacturer’s wellness claims)

Identity and chemistry

NAC is a manufactured acetylated form of L-cysteine, not a harvested herb. The acetyl group changes the parent amino acid’s properties; a free thiol group contributes to its reducing chemistry. The body can use resulting cysteine for glutathione production. Its biochemical plausibility should be separated from evidence that a particular product improves a meaningful health outcome. Botanical-family and herb-part fields therefore do not apply.

PubChem: N-acetyl-L-cysteine, identity and molecular formula · National Cancer Institute: Acetylcysteine drug dictionary

Mucus and glutathione are different targets

In mucus, acetylcysteine can reduce disulfide links, chemical bridges that help hold mucus proteins together. In the body it also supplies cysteine used to make glutathione. These mechanisms explain why the same compound has different medical applications; a laboratory antioxidant measurement alone does not demonstrate a clinical benefit.

National Cancer Institute: Acetylcysteine drug dictionary · DailyMed: Acetylcysteine solution, oral antidote and inhaled mucolytic labeling

Food, nutrition and oral absorption

Digesting protein supplies amino acids, and cysteine is normally also made within the body. This does not create an RDA for NAC or make a protein food equivalent to an NAC dose. Oral NAC undergoes substantial first-pass metabolism and conversion to cysteine. Formulation instructions differ: the Sovereign oral powder allows food or no food, whereas Acepiro directs after-food use. Pharmacokinetics do not establish that fasting, added oil, vitamin C or larger doses will improve clinical results.

MedlinePlus: Amino acids, protein digestion and cysteine · MedlinePlus: Dietary protein and food sources · Acepiro 600 mg: UK product information, absorption, food and precautions (2025) · Sovereign Medical: Acetylcysteine 200 mg oral powder, UK product information (2025)

Uses in brief

  • Established medicine: acetaminophen/paracetamol antidote under urgent medical care; mucus-thinning treatment in specified respiratory conditions.
  • Supplement research: selected respiratory and psychiatric uses have condition-specific, mixed results. Routine general-wellness benefit is not established.

History, folklore and reported uses

Medical history and different routes

NAC has a pharmaceutical history rather than an established herbal tradition. Its modern roles include thinning tenacious respiratory mucus and treating acetaminophen toxicity. U.S. oral/inhaled acetylcysteine solution is specifically labeled not for injection; ACETADOTE is a separate IV product. Some countries also license oral tablets or powders as mucolytics. Route, concentration, preparation and indication all matter; the presence of the same molecule does not make products interchangeable.

DailyMed: Acetylcysteine solution, oral antidote and inhaled mucolytic labeling · DailyMed: ACETADOTE intravenous acetylcysteine prescribing information (2025) · NACSYS 600 mg: UK product information and mucolytic mechanism

From laboratory chemistry to respiratory medicine

NAC’s story belongs to the age of pharmaceutical chemistry. Its early public identity was a medicine that could loosen thick mucus: the American Association for Respiratory Care’s museum dates the introduction of Mucomyst, an acetylcysteine preparation, to 1963. The small medicine bottle marks the beginning of a very different journey from that of a gathered herb. Here, a manufactured derivative of the amino acid cysteine acquired a place in everyday health culture through its medical uses.

American Association for Respiratory Care Virtual Museum: Early Inhalation Therapy Medications, 1963 Mucomyst entry

The emergency-medicine chapter

A second chapter opened in the 1970s, as researchers looked for ways to prevent liver injury after paracetamol, also called acetaminophen, poisoning. Work on the body’s protective molecule glutathione helped explain why supplying cysteine could matter. In 1977, Laurie Prescott and colleagues reported intravenous NAC treatment in fifteen patients. That history belongs to supervised emergency medicine; it is not a home-treatment recipe.

Prescott and colleagues (1977): Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine (original report) · History of Modern Clinical Toxicology (2022): N-Acetylcysteine, history of mucolytic and antidote development

A place in modern supplement culture

NAC later found another audience on supplement shelves, where the language shifted toward antioxidant protection, cellular health and detoxification. NOW Foods, for example, links its NAC product to glutathione and includes NAC in its detox-and-liver-support range. The connecting thread is the same biochemical molecule, retold for a wellness audience. This is NAC’s modern natural-health heritage: medical discoveries, supplement marketing and hopes for everyday resilience.

NOW Foods: NAC capsules (primary source for the manufacturer’s wellness claims) · NOW Foods: Detox & Liver Support (primary source for the manufacturer’s product positioning)

Reading the recorded uses

These entries follow NAC from licensed medicines into supplement marketing and clinical investigation. A mucolytic loosens mucus; an antidote counters a particular poison. Adjunctive treatment is added to another treatment rather than replacing it. PCOS means polycystic ovary syndrome, a condition involving hormonal and ovulatory disturbances. Manufacturer wellness claims are evidence of marketing, not proof that the advertised health outcomes occur.

DailyMed: Acetylcysteine solution, oral antidote and inhaled mucolytic labeling · Memorial Sloan Kettering: NAC evidence, cancer-treatment cautions and interactions · Fulghesu and colleagues, 2002: NAC and insulin sensitivity in polycystic ovary syndrome · NOW Foods: NAC capsules (primary source for the manufacturer’s wellness claims)

Loosening respiratory mucus

The respiratory-care museum dates the introduction of Mucomyst acetylcysteine to 1963. Inhaled and some oral medicinal preparations were used to thin tenacious mucus, an established pharmaceutical history rather than an ancient herbal tradition.

American Association for Respiratory Care Virtual Museum: Early Inhalation Therapy Medications, 1963 Mucomyst entry · Memorial Sloan Kettering: NAC evidence, cancer-treatment cautions and interactions

An antidote in poisoning care

By the 1970s, NAC was being developed to prevent liver injury after paracetamol/acetaminophen poisoning; Prescott and colleagues reported intravenous treatment in 1977. This is supervised emergency medicine, and suspected overdose requires immediate medical care rather than a supplement.

Prescott and colleagues (1977): Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine (original report)

Cellular, immune and liver “detox” claims

Modern manufacturer NOW Foods markets oral NAC for cellular health, free-radical protection and immune support, and includes it in its detox-and-liver-support range. This wellness presentation links glutathione with everyday resilience, extending beyond NAC’s specific medical antidote role.

NOW Foods: NAC capsules (primary source for the manufacturer’s wellness claims) · NOW Foods: Detox & Liver Support (primary source for the manufacturer’s product positioning)

Mood and repetitive-behavior research

Twenty-first-century psychiatry has investigated oral NAC as an adjunct for depression and repetitive or compulsive behaviors, including hair pulling and skin picking. Memorial Sloan Kettering documents this research and its mixed findings; it is not a general substitute for mental-health care.

Memorial Sloan Kettering: NAC evidence, cancer-treatment cautions and interactions · Grant et al. (2016): Randomized trial of NAC for excoriation (skin-picking) disorder

PCOS and fertility-related investigation

Beginning in the early 2000s, researchers explored NAC for insulin sensitivity in PCOS and later as an adjunct in ovulation-treatment studies. These are modern reproductive-medicine investigations of a manufactured cysteine derivative, not a traditional food remedy or a proven universal fertility aid.

Fulghesu and colleagues, 2002: NAC and insulin sensitivity in polycystic ovary syndrome · Abu Hashim and colleagues, 2010: NAC plus clomiphene in resistant PCOS

Identity & detailed reference

Identity

N-acetyl-L-cysteine, also called acetylcysteine or NAC, is an acetylated derivative of the amino acid L-cysteine. It is a manufactured single compound, not a botanical or an essential vitamin.

Ingredient details, preparation and research

Source plant or material

Not a plant extract. Commercial NAC is manufactured by acetylating L-cysteine; the starting material and processing depend on the manufacturer.

Plant family / material: Not applicable: an amino-acid derivative rather than a plant.

Forms and route

Oral capsules, tablets and powders sold as supplements; separately, licensed oral mucolytic medicines in some countries, prescription oral antidote preparations, inhalation solutions and intravenous antidote formulations. A supplement, nebulizer solution and IV vial are not interchangeable. Never inject or nebulize an oral supplement.

Food sources

Ordinary protein foods supply amino acids including cysteine, rather than an equivalent dose of manufactured NAC. Meat, fish, eggs, dairy, beans, lentils, nuts and seeds can contribute dietary protein. Eating protein is not a substitute for medical acetylcysteine treatment.

Vitamins and minerals

NAC has no established Recommended Dietary Allowance (RDA) and is not an essential vitamin or mineral. There is no standard dietary NAC target or dependable food-NAC equivalent to a capsule. The body ordinarily makes cysteine as well as obtaining it through protein; requirements can change in illness. Label milligrams describe the ingredient, not a daily nutritional requirement.

Absorption and preparation

Oral NAC is absorbed but extensively metabolized in the intestinal wall and liver; little unchanged NAC reaches systemic circulation. This does not mean it is inactive, because conversion to cysteine is relevant to its effects. Follow the specific label: one licensed oral powder permits use with or without food, while Acepiro specifies after food. No universal empty-stomach rule, fat pairing or antioxidant stack is established.

Traditional and reported uses

  • Biochemistry: NAC is a cysteine precursor, supporting the body’s synthesis of glutathione. This mechanism alone does not demonstrate better health or establish a need for supplementation.
  • Established clinical care: prescription oral or IV acetylcysteine can prevent or lessen liver injury after a potentially toxic acetaminophen/paracetamol exposure. This does not establish general liver repair, alcohol protection or routine detoxification.
  • Respiratory use: inhaled acetylcysteine and certain licensed oral medicines loosen thick mucus. Oral COPD trials have produced differing results across patient groups; it is not a replacement for prescribed inhalers or acute care.
  • Investigational/off-label use: small studies suggest benefit for some body-focused repetitive behaviors, while depression and substance-use results are inconsistent. A diagnosis-specific treatment plan is needed.

Contraindications and cautions

  • Oral NAC can cause nausea, abdominal discomfort, diarrhea, reflux or vomiting. Stop and seek urgent help for breathing difficulty, facial/throat swelling or a severe allergic reaction.
  • Asthma or a history of bronchospasm calls for medical review. Inhaled acetylcysteine can provoke unpredictable bronchospasm; IV treatment has separate monitored hypersensitivity risks. Do not transfer the frequency or severity of infusion reactions directly to ordinary oral use.
  • Nitroglycerin can interact with NAC to increase blood-pressure lowering and headache. Have the prescriber or pharmacist review the combination before starting a supplement.
  • If using NAC as a mucolytic, review cough suppressants and antibiotics with a pharmacist. Certain oral product labels advise antibiotic spacing and warn that suppressing the cough can retain loosened secretions; instructions are formulation-specific.
  • Use in pregnancy, breastfeeding or children should be clinician-directed. This precaution about elective supplementation must not delay emergency antidote treatment when poisoning is suspected.
  • Ask the oncology team before use during cancer treatment. Antioxidant effects do not prove cancer prevention, and compatibility depends on the treatment; preclinical findings cannot establish either benefit or harm for every patient.
  • No universal dose or indefinite-use plan is established for a healthy person. Product strength, intended indication, other medicines and relevant medical conditions matter.
  • Acepiro’s oral label calls for caution with a history of peptic ulcers, histamine intolerance, or kidney or liver impairment. People unable to cough mucus up effectively need clinical assessment before a mucolytic. Its effervescent tablets contain sodium and lactose; check the actual product when salt restriction or relevant sugar intolerance matters.
  • Very rare serious skin reactions have been reported in temporal association with acetylcysteine. Acepiro’s label advises stopping use and seeking immediate medical advice for new skin or mucosal lesions; the association alone does not establish that NAC caused every reported case.
  • ACETADOTE infusion can cause fluid overload and dangerously low blood sodium, in addition to its hypersensitivity risks. These are hospital-treatment precautions, not evidence that oral supplements have the same risk profile.

Similar items and how they compare

  • Cysteine and dietary protein

    Cysteine is the amino acid underlying NAC and a building block used to make glutathione.

    Food protein and unacetylated cysteine are not dose-equivalent substitutes for NAC medicines. NAC supplies no meaningful balance of all dietary amino acids.

  • Glutathione

    NAC provides a precursor used in the body’s glutathione production.

    Glutathione is a distinct molecule; taking its precursor and taking glutathione are different interventions. Changes in glutathione measurements do not by themselves establish a clinical benefit.

  • Vitamin C

    Both are discussed in relation to antioxidant biology.

    Vitamin C is an essential nutrient with an RDA and roles including collagen synthesis and non-heme iron absorption. NAC does not replace those nutritional functions; combining them has no universal requirement.

Antidote use and the limits of detox claims

Acetaminophen overdose can deplete liver glutathione, and prescribed NAC is used to prevent or reduce the resulting injury. Hospital assessment and treatment depend on exposure history, blood tests and clinical status, not an over-the-counter serving size. Suspected poisoning requires immediate medical advice even if symptoms have not yet appeared. This highly specific benefit does not establish that a healthy person needs a daily cleanse, that NAC prevents alcohol damage, or that it treats every cause of abnormal liver tests.

Respiratory evidence is population-specific

The 2014 PANTHEON trial randomized 1,006 people with moderate-to-severe COPD in China and found fewer exacerbations with 600 mg twice daily over one year. A 2024 trial of 968 people with mild-to-moderate COPD used the same daily regimen for two years but did not significantly improve its primary total-exacerbation or lung-function outcomes. These are research regimens, not a blanket supplement recommendation. The contrast supports tailoring clinical decisions to the condition and existing treatment.

Mood, repetitive behaviors and substance-use research

A 12-week trial in 66 adults with skin-picking disorder found a symptom benefit, but did not show a significant psychosocial-functioning difference. A 252-person major-depression trial did not meet its primary week-12 endpoint despite some secondary signals. In 2025, a 192-participant youth cannabis-use trial found no abstinence advantage without a contingency-management program and more gastrointestinal adverse events. These different diagnoses and treatment settings cannot be combined into a claim that NAC reliably improves mood, compulsions or cravings for everyone.

Adverse effects, asthma and medicine interactions

Gastrointestinal intolerance is a practical concern with oral products. Asthma deserves review because bronchospasm is a recognized warning, especially with inhaled treatment. Serious IV hypersensitivity occurs in a different clinical setting and is managed with monitoring. Nitroglycerin deserves particular attention: enhanced vasodilation and severe headache have been observed in a human trial. Mucolytic product labels also address cough suppressants and certain oral antibiotics; use a pharmacist’s instructions rather than assuming every medicine needs the same spacing.

Pregnancy, breastfeeding and cancer care

Elective supplement use during pregnancy or breastfeeding needs an individual clinical assessment; oral product information is not identical across formulations. When acetaminophen poisoning occurs in pregnancy, delaying necessary treatment can endanger both mother and fetus. During cancer care, have the oncology team review NAC before starting: effects on treatment efficacy and side effects are not settled, and laboratory antioxidant activity is not proof of cancer prevention.

Supplement status and practical interpretation

At this review, FDA’s published 2022 policy describes enforcement discretion for certain NAC-containing products labeled as dietary supplements, despite the agency’s drug-exclusion position. It does not approve disease-treatment claims for those products or establish their efficacy. Regulatory availability varies by country. For personal use, first identify the intended problem, the exact product and any interacting treatment; no general healthy-person indication or universal dose follows from NAC’s medical history.

Entry sources